Atlas Trials

Alternating HAIC and Systemic Chemotherapy With or Without Adebrelimab and Apatinib for Unresectable Biliary Tract Cancer

Clinical trial NCT07569679 · RECRUITING

Trial details

NCT number
NCT07569679
Sponsor
Air Force Military Medical University, China
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Biliary Tract Cancer
Start date
2025-12-10
Primary completion
2028-12-30
Enrollment
124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.